1. CD23 Mediates Antimycobacterial Activity of Human Macrophages
- Author
-
Maria Mamani-Matsuda, Jérôme Rambert, Ioannis Vouldoukis, M. Djavad Mossalayi, Denis Malvy, Vanessa Desplat, Tina Kauss, Philippe Vincendeau, Jeanne Maugein, Dominique Mazier, Daniel Moynet, and Jean Guillon
- Subjects
medicine.medical_treatment ,Immunology ,Nitric Oxide ,Microbiology ,Immune system ,medicine ,Humans ,Macrophage ,Cells, Cultured ,Microbial Viability ,Cellular Microbiology: Pathogen-Host Cell Molecular Interactions ,biology ,Receptors, IgE ,Tumor Necrosis Factor-alpha ,Macrophages ,CD23 ,Interleukin-10 ,Interleukin 10 ,Infectious Diseases ,Cytokine ,Cell culture ,biology.protein ,Parasitology ,Tumor necrosis factor alpha ,Antibody ,Mycobacterium avium - Abstract
Engagement of surface receptors contributes to the antimicrobial activity of human immune cells. We show here that infection of human monocyte-derived macrophages (MDM) with liveMycobacterium aviuminduced the expression of CD23 on their membrane. Subsequent cross-linking of surface CD23 by appropriate ligands induced a dose-dependent antibacterial activity of MDM and the elimination of most infected cells. The stimulation of inducible nitric oxide synthase-dependent generation of NO from MDM after CD23 activation played a major role during their anti-M. aviumactivity. CD23 activation also induced tumor necrosis factor alpha (TNF-α) production from MDM. Mycobacteria reduction was partially inhibited by the addition of neutralizing anti-TNF-α antibody to cell cultures without affecting NO levels, which suggested the role of this cytokine for optimal antimicrobial activity. Finally, interleukin-10, a Th2 cytokine known to downregulate CD23 pathway, is shown to decrease NO generation and mycobacteria elimination by macrophages. Therefore, (i) infection withM. aviumpromotes functional surface CD23 expression on human macrophages and (ii) subsequent signaling of this molecule contributes to the antimicrobial activity of these cells through an NO- and TNF-α-dependent pathway. This study reveals a new human immune response mechanism to counter mycobacterial infection involving CD23 and its related ligands.
- Published
- 2009
- Full Text
- View/download PDF